Mometasone Furoate Monohydrate Spray, Metered
Product Images NDC 59651-402

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Mometasone Furoate Monohydrate (NDC 59651-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Mometasone Fig1)

This text seems to be a description of a plastic applicator bottle used for dispensing liquids. It likely shows a figure or diagram of the bottle.*

FDA Label Image

Fig10 (Mometasone Fig10)

FDA Label Image

Fig11 (Mometasone Fig11)

FDA Label Image

Package Label-principal Display Panel (50 mcg Container Label (120 Metered Sprays))

This is a description for a nasal spray containing Mometasone Furoate monohydrate, which is used for intranasal use. Each spray delivers a specific dosage of the active ingredient and is distributed by Aurobindo Pharma USA, Inc. The ingredients include cellulose, benzalkonium chloride, microcrystalline cellulose, and various other substances. The product is made in India and should be stored at the recommended temperature range. It is important to read the accompanying directions carefully and shake well before each use.*

FDA Label Image

Package Label-principal Display Panel (50 mcg Container Carton Label (120 Metered Sprays))

This description is a detailed label for Mometasone Furoate Monohydrate Nasal Spray. It includes information such as dosage and administration instructions for allergic rhinitis, storage conditions, manufacturer details (Aurobindo Pharma USA, Inc.), and contact information for more information. Additionally, it provides details on the contents of the spray, the unique serial number on each carton, and specific instructions for dispensing and use.*

FDA Label Image

Fig2 (Mometasone Fig2)

FDA Label Image

Fig3 (Mometasone Fig3)

FDA Label Image

Fig4 (Mometasone Fig4)

This text provides instructions on using the Mometasone Furoate Monohydrate Nasal Spray unit. It emphasizes the importance of keeping the unit in an upright orientation to ensure proper spray functionality. Failure to maintain the correct position may lead to an incomplete or non-existent spray.*

FDA Label Image

Fig5 (Mometasone Fig5)

FDA Label Image

Fig6 (Mometasone Fig6)

FDA Label Image

Fig7 (Mometasone Fig7)

FDA Label Image

Fig8 (Mometasone Fig8)

This text provides information about a plastic cap with a reference to Figure 8, suggesting it could be related to a product design, schematics, or manual.*

FDA Label Image

Fig9 (Mometasone Fig9)

This appears to be a description of a white nasal applicator with a center hole and the text "PUMPSTEN". There is also a reference to a figure 8 shape.*

FDA Label Image

Structure (Mometasone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.